(Q52936396)

English

CD52 is not a promising immunotherapy target for most patients with multiple myeloma.

scientific article published in October 2005

Statements

CD52 is not a promising immunotherapy target for most patients with multiple myeloma. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit